Quick Answer
MEDIFAST INC reported Total Revenue of $385.79 million for fiscal year 2025.
MEDIFAST INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $385.79M -36.0% |
$602.46M -43.8% |
$1.07B -32.9% |
$1.60B +4.8% |
$1.53B +63.2% |
$934.84M +31.0% |
| Revenue (ASC 606) | $385.79M -36.0% |
$602.46M -43.8% |
$1.07B -32.9% |
$1.60B +4.8% |
$1.53B | — |
| Net Income | -$18.67M -993.0% |
$2.09M -97.9% |
$99.42M -30.8% |
$143.57M -12.5% |
$164.03M +59.5% |
$102.86M +32.0% |
| Diluted EPS | -$1.70 -994.7% |
$0.19 -97.9% |
$9.10 -28.5% |
$12.73 -8.4% |
$13.89 +60.0% |
$8.68 +35.0% |
| Total Assets | $247.97M -12.8% |
$284.21M -8.3% |
$309.91M -2.0% |
$316.21M -20.6% |
$398.33M +44.3% |
$276.08M +41.8% |
| Cash and Equivalents | $89.30M -1.8% |
$90.93M -3.7% |
$94.44M +7.7% |
$87.69M -15.8% |
$104.18M -36.4% |
$163.72M +112.7% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $198.92M -5.3% |
$210.11M +4.3% |
$201.48M +30.0% |
$155.04M -23.4% |
$202.47M +28.8% |
$157.25M +50.0% |
| Operating Income | -$14.21M -593.8% |
$2.88M -97.7% |
$126.40M -31.6% |
$184.81M -14.5% |
$216.24M +61.2% |
$134.16M +47.4% |
| Gross Profit | $275.19M -38.1% |
$444.62M -42.7% |
$775.85M -32.0% |
$1.14B +1.1% |
$1.13B +61.6% |
$697.82M +30.0% |
| Shares Outstanding | 10.99M +0.5% |
10.94M +0.4% |
10.90M +0.2% |
10.87M -6.2% |
11.59M -1.5% |
11.77M +0.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $89.41M | -36.2% | -15.3% |
| Revenue (ASC 606) | September 30, 2025 | $89.41M | -36.2% | -15.3% |
| Net Income | September 30, 2025 | -$2.26M | -300.3% | -191.2% |
| Diluted EPS | September 30, 2025 | -$0.21 | -310.0% | -195.5% |
| Total Assets | September 30, 2025 | $268.21M | -7.9% | -0.4% |
| Cash and Equivalents | September 30, 2025 | $99.53M | -13.7% | -2.1% |
| Long-Term Debt | September 30, 2013 | $0.00 | -100.0% | — |
| Stockholders Equity | September 30, 2025 | $214.71M | +3.6% | -0.6% |
| Operating Income | September 30, 2025 | -$4.08M | -293.8% | -282.8% |
| Gross Profit | September 30, 2025 | $62.16M | -41.2% | -18.9% |
| Shares Outstanding | September 30, 2025 | 10.99M | +0.5% | +0.0% |
- MEDIFAST INC reported Total Revenue of $385.79 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -36.0% in Total Revenue compared to the prior fiscal year.
- MEDIFAST INC reported Revenue (ASC 606) of $385.79 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -36.0% in Revenue (ASC 606) compared to the prior fiscal year.
- MEDIFAST INC reported Net Income of -$18.67 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -993.0% in Net Income compared to the prior fiscal year.
- MEDIFAST INC reported Diluted EPS of $1.70 per share (loss) for fiscal year 2025.
- MEDIFAST INC showed a decrease of -994.7% in Diluted EPS compared to the prior fiscal year.
- MEDIFAST INC reported Total Assets of $247.97 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -12.8% in Total Assets compared to the prior fiscal year.
- MEDIFAST INC reported Cash and Equivalents of $89.30 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -1.8% in Cash and Equivalents compared to the prior fiscal year.
- MEDIFAST INC reported Long-Term Debt of $0.00 for fiscal year 2013.
- MEDIFAST INC showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- MEDIFAST INC reported Stockholders Equity of $198.92 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -5.3% in Stockholders Equity compared to the prior fiscal year.
- MEDIFAST INC reported Operating Income of -$14.21 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -593.8% in Operating Income compared to the prior fiscal year.
- MEDIFAST INC reported Gross Profit of $275.19 million for fiscal year 2025.
- MEDIFAST INC showed a decrease of -38.1% in Gross Profit compared to the prior fiscal year.
- MEDIFAST INC reported Shares Outstanding of 10.99 million shares for fiscal year 2025.
- MEDIFAST INC showed an increase of +0.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: